×

Methods for treating conditions associated with MASP-2 dependent complement activation

  • US 7,919,094 B2
  • Filed: 12/22/2006
  • Issued: 04/05/2011
  • Est. Priority Date: 06/10/2004
  • Status: Active Grant
First Claim
Patent Images

1. A method of inhibiting MASP-2-dependent complement activation in a subject suffering from or age-related macular degeneration, comprising administering to the subject an amount of a MASP-2 inhibitory agent effective to inhibit MASP-2-dependent complement activation, wherein the MASP-2 inhibitory agent comprises an anti-MASP-2 antibody or fragment thereof that specifically binds to a portion of SEQ ID NO:

  • 6.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×